nChroma Bio is a genetic medicines company developing durable in vivo therapies by pairing best-in-class genetic cargoes, including epigenetic editing approaches, with targeted delivery technologies for diseases of significant unmet need. Headquartered at 201 Brookline Avenue in Boston, Massachusetts, the company is backed by DCVC and GV.
company drug-discovery life-sciences biotechnology apis-json therapeutics genetic-medicines epigenetic-editing
-
Updated
Aug 14, 2026